Developing safe and effective gene therapies using viral vectors
Viral Vector and Regulatory Core
This study is working on making safer and better gene therapies using special tools called AAV vectors, which help deliver treatments to patients, so you can expect improved options for your condition in the future!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jackson Laboratory NIH-funded |
| Lab location | 1 site (Bar Harbor, United States) |
| Project ID | NIH-11089349 on NIH RePORTER |
What this research studies
This research focuses on the development and regulatory management of adeno-associated viral (AAV) vectors for gene therapy applications. It aims to ensure the safe and effective production of these vectors, which are crucial for delivering gene-editing treatments. The project includes creating protocols to manage immune responses to these therapies and navigating the regulatory pathways necessary for clinical trials. Patients may benefit from improved gene therapies that are safer and more effective due to rigorous testing and quality control.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals with genetic disorders that could be treated with gene therapy.
Not a fit: Patients with conditions that are not amenable to gene therapy or those who do not have genetic disorders may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective gene therapies for various genetic conditions.
How similar studies have performed: Previous research has shown success in using AAV vectors for gene therapy, indicating a promising approach for future treatments.
Where this research is happening
Bar Harbor, United States
- Jackson Laboratory — Bar Harbor, United States (Active)
Researchers
- Principal investigator: Gray, Steven J — Jackson Laboratory
- Study coordinator: Gray, Steven J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.